# NEUROCRINE BIOSCIENCES, INC. (NBIX) FY2026 Q2 Balance Sheet

- Company: NEUROCRINE BIOSCIENCES, INC. (NBIX)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-31, accession number 0000914475-26-000037
- Page: https://plicit.ai/financials/nbix/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/nbix-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 5,359,100,000 US dollars
- **Current assets**: 1,637,500,000 US dollars
- **Non-current assets**: 3,721,600,000 US dollars
- **Liabilities**: 1,665,500,000 US dollars
- **Current liabilities**: 874,500,000 US dollars
- **Non-current liabilities**: 791,000,000 US dollars
- **Equity**: 3,693,600,000 US dollars
- **Accounts receivable**: 887,000,000 US dollars
- **Cash and cash equivalents**: 332,400,000 US dollars
- **Prepaid expenses**: 217,100,000 US dollars
- **Inventory**: 104,200,000 US dollars
- **Available-for-sale debt securities**: 57,400,000 US dollars
- **Other current assets**: 39,400,000 US dollars
- **Intangible assets, net**: 2,226,000,000 US dollars
- **Goodwill**: 500,600,000 US dollars
- **Right-of-use assets**: 448,000,000 US dollars
- **Noncurrent inventory**: 149,100,000 US dollars
- **Equity investments**: 147,300,000 US dollars
- **Noncurrent available-for-sale debt securities**: 91,900,000 US dollars
- **Property and equipment, net**: 90,500,000 US dollars
- **Other noncurrent assets**: 59,300,000 US dollars
- **Deferred tax assets**: 8,900,000 US dollars
- **Accounts payable and accrued liabilities**: 808,300,000 US dollars
- **Other current liabilities**: 66,200,000 US dollars
- **Noncurrent operating lease liabilities**: 401,800,000 US dollars
- **Other noncurrent liabilities**: 297,700,000 US dollars
- **Deferred tax liabilities**: 91,500,000 US dollars
- **Additional paid-in capital**: 2,964,400,000 US dollars
- **Retained earnings**: 724,000,000 US dollars
- **Accumulated other comprehensive income**: 5,100,000 US dollars
- **Common stock, $0.001 par value; 220.0 shares authorized; 101.6 and 100.1 shares issued and outstanding, respectively**: 100,000 US dollars
- **Preferred stock, $0.001 par value; 5.0 shares authorized; no shares issued and outstanding**: 0 US dollars

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.